These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6172314)

  • 1. Cholecystokinin-octapeptidelike immunoreactivity in human plasma.
    Walsh JH; Lamers CB; Valenzuela JE
    Gastroenterology; 1982 Mar; 82(3):438-44. PubMed ID: 6172314
    [No Abstract]   [Full Text] [Related]  

  • 2. Large molecular forms of cholecystokinin circulating in humans.
    Gaisano HY; Reilly W; Go VL; Olivero D; Miller LJ
    Pancreas; 1986; 1(2):148-53. PubMed ID: 2437562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reactivity of mononucleotides with cholecystokinin/gastrin antisera.
    Rehfeld JF
    Regul Pept; 1983 Apr; 6(1):33-41. PubMed ID: 6867379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of gastrinlike and cholecystokininlike peptides released in dogs in response to a peptone meal.
    Wolfe MM; McGuigan JE
    Gastroenterology; 1984 Aug; 87(2):323-34. PubMed ID: 6203807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin/cholecystokinin-like immunoreactivity in human blood cells.
    Okahata H; Nishi Y; Muraki K; Sumii K; Miyachi Y; Usui T
    Life Sci; 1985 Jan; 36(4):369-73. PubMed ID: 3965853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides.
    Robberecht P; Deschodt-Lanckman M; Woussen-Colle MC; De Neef P; Camus JC; Christophe J
    Mol Pharmacol; 1980 Mar; 17(2):268-74. PubMed ID: 6156397
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin.
    Robberecht P; Deschodt-Lanckman M; Vanderhaeghen JJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):524-8. PubMed ID: 272670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of the endocrine pancreas. Evidence for the presence of cholecystokinin- pancreozymin within the A-cell.
    Grube D; Maier V; Raptis S; Schlegel W
    Histochemistry; 1978 Jun; 56(1):13-35. PubMed ID: 77855
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.
    Liddle RA; Goldfine ID; Williams JA
    Gastroenterology; 1984 Sep; 87(3):542-9. PubMed ID: 6204904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cholecystokinin in conscious dogs: correlation with simultaneous measurements of gallbladder pressure and pancreatic protein secretion.
    Fried GM; Ogden WD; Swierczek J; Greeley GH; Rayford PL; Thompson JC
    Gastroenterology; 1983 Nov; 85(5):1113-9. PubMed ID: 6618104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of cholecystokinin-like immunoreactivity in the human brain.
    Geola FL; Hershman JM; Warwick R; Reeve JR; Walsh JH; Tourtellotte WW
    J Clin Endocrinol Metab; 1981 Aug; 53(2):270-5. PubMed ID: 6265485
    [No Abstract]   [Full Text] [Related]  

  • 13. CCK-58 is the only detectable endocrine form of cholecystokinin in rat.
    Reeve JR; Green GM; Chew P; Eysselein VE; Keire DA
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G255-65. PubMed ID: 12686511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis.
    Owyang C; Scarpello JH; Vinik AI
    Gastroenterology; 1982 Jul; 83(1 Pt 1):55-62. PubMed ID: 6281125
    [No Abstract]   [Full Text] [Related]  

  • 16. Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output.
    Anagnostides A; Chadwick VS; Selden AC; Maton PN
    Gastroenterology; 1984 Jul; 87(1):109-14. PubMed ID: 6724252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of synthetic secretin, cholecystokinin-octapeptide and combinations of these hormones on the secretion of the isolated perfused rat pancreas.
    Sommer H; Kasper H
    Hepatogastroenterology; 1981 Dec; 28(6):311-5. PubMed ID: 6178671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat.
    Valenzuela JE; Defilippi C
    Gastroenterology; 1981 Nov; 81(5):898-902. PubMed ID: 6269946
    [No Abstract]   [Full Text] [Related]  

  • 19. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
    Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
    Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intravenously administered sincalide on the human gallbladder during oral cholecystography.
    Katevuo K; Kanto J
    Ann Clin Res; 1982 Aug; 14(4):157-9. PubMed ID: 6301354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.